Back
Nova Mentis Life Science Vs. Algernon Pharmaceuticals Industry Stock Comparison
Sell
13
NOVA.CX
Nova Mentis Life Science
Last Price:
0.0100
Seasonality Move:
31.15%
Buy
61
AGN.CX
Algernon Pharmaceuticals
Last Price:
0.09
Seasonality Move:
42.23%
Sell
13
Nova Mentis Life Science (NOVA.CX)
is a Sell
Is Nova Mentis Life Science a Buy, Sell or Hold?
- The current Nova Mentis Life Science [NOVA.CX] share price is $0.0050. The Score for NOVA.CX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- NOVA.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Algernon Pharmaceuticals (AGN.CX)
is a Buy
Is Algernon Pharmaceuticals a Buy, Sell or Hold?
- The current Algernon Pharmaceuticals [AGN.CX] share price is $0.09. The Score for AGN.CX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- AGN.CX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NOVA.CX Stock Price Chart
What is Nova Mentis Life Science's stock price today?
-
The Nova Mentis Life Science share price today is $0.0050
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOVA.CX is experiencing slight buying pressure.
AGN.CX Stock Price Chart
What is Algernon Pharmaceuticals's stock price today?
-
The Algernon Pharmaceuticals share price today is $0.09
The current trend is relatively stagnant and AGN.CX is experiencing slight buying pressure.
NOVA.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 40.31 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0058 - 0.0058) | Sell |
| Bollinger Bands (100): | (0.0099 - 0.0099) | Sell |
AGN.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 49.37 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.08) | Buy |
| Bollinger Bands (100): | (0.09 - 0.13) | Sell |
NOVA.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.01 | Sell |
| 20-day SMA: | 0.01 | Sell |
| 50-day SMA: | 0.01 | Sell |
| 200-day SMA: | 0.01 | Sell |
| 8-day EMA: | 0.01 | Sell |
| 20-day EMA: | 0.01 | Sell |
| 50-day EMA: | 0.01 | Sell |
| 200-day EMA: | 0.01 | Sell |
AGN.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Buy |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.09 | Sell |
| 200-day SMA: | 0.11 | Sell |
| 8-day EMA: | 0.08 | Buy |
| 20-day EMA: | 0.08 | Buy |
| 50-day EMA: | 0.09 | Sell |
| 200-day EMA: | 0.12 | Sell |
Nova Mentis Life Science Earnings Growth & NOVA.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Algernon Pharmaceuticals Earnings Growth & AGN.CX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.00 per share.
Nova Mentis Life Science Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Algernon Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||